Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 1, 2008, Pages 22-30

  Collings, A ^a   Raitakari, O T ^b   Juonala, M ^c   Rontu, R ^a   Kahonen M ^a   Hutri Kahonen N ^a   Ronnemaa T ^b   Marniemi, J ^d   Viikari, J S A ^b   Lehtimaki T ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Atherosclerosis; Homocysteine; Methylenetetrahydrofolate reductase; SNP

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADOLESCENT; ADULT; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SMOKING; SYSTOLIC BLOOD PRESSURE; ULTRASOUND;

ADULT; AGE FACTORS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; FEMALE; FINLAND; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; LIPIDS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; VASODILATION;

EID: 38549097696     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701487735     Document Type: Article

References (40)

1. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991;134:250-6.
2. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr.. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
3. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478-87.
4. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002;39:10-15.
5. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570-4.
6. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358:1400-4.
7. Juonala M, Järvisalo MJ, Mäki-Torkko N, Kähönen M, Viikari JS, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation 2005;112:1486-93.
8. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: The Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 2005;165:875-82.
9. Riley WA, Barnes RW, Evans GW, Burke GL. Ultrasonic measurement of the elastic modulus of the common carotid artery. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1992;23:952-6.
10. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-15.
11. Juonala M, Viikari JS, Laitinen T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: The Cardiovascular Risk in Young Finns Study. Circulation 2004;110:2918-23.
12. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. J Am Med Assoc 2002;288:2015-22.
13. Kang SS, Wong PW, Zhou JM, et al. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988;37:611-13.
14. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis. J Am Med Assoc 2002;288:2023-31.
15. Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation 1998;98:2520-6.
16. Kawamoto R, Kohara K, Tabara Y, et al. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J Hum Genet 2001;46:506-10.
17. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999;99:2383-8.
18. Kelemen LE, Anand SS, Hegele RA, et al. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis 2004;176:361-70.
19. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: A critical appraisal of the evidence. Atherosclerosis 2004;176:1-19.
20. Tsai JC, Kuo HT, Chiu YW, et al. Correlation of plasma homocysteine level with arterial stiffness and pulse pressure in hemodialysis patients. Atherosclerosis 2005;182:121-7.
21. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 2005;82:26-31.
22. Pullin CH, Wilson JF, Ashfield-Watt PA, et al. Influence of methylenetetrahydrofolate reductase genotype, exercise and other risk factors on endothelial function in healthy individuals. Clin Sci (Lond) 2002;102:45-50.
23. Imamura A, Okumura K, Matsui H, et al. Endothelial nitric oxide synthase and methylenetetrahydrofolate reductase gene polymorphisms are associated with endothelial dysfunction in young, healthy men. Can J Cardiol 2004;20:1229-34.
24. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. J Am Med Assoc 2003;290:2277-83.
25. Juonala M, Viikari JS, Hutri-Kähönen N, et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: Risk factor levels, secular trends and east-west difference. J Intern Med 2004;255:457-68.
26. Åkerblom HK, Viikari J, Uhari M, et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand Suppl 1985;318:49-63.
27. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-9.
28. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993;39:1764-79.
29. Inamoto N, Katsuya T, Kokubo Y, et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 2003;34:1628-33.
30. Pallaud C, Sass C, Zannad F, Siest G, Visvikis S. APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 2001;59:316-24.
31. Passaro A, Vanini A, Calzoni F, et al. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 2001;157:175-80.
32. Mazza A, Motti C, Nulli A, et al. Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects. J Thromb Thrombolysis 1999;8:207-12.
33. Durga J, Bots ML, Schouten EG, Kok FJ, Verhoef P. Low concentrations of folate, not hyperhomocysteinemia, are associated with carotid intima-media thickness. Atherosclerosis 2005;179:285-92.
34. Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventive potential of folate? Br Med J 2005;331:1053.
35. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: Evidence on a causal link from Mendelian randomisation. Lancet 2005;365:224-32.
36. Bortolotto LA, Safar ME, Billaud E, et al. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999;34:837-42.
37. Wilkinson IB, Megson IL, MacCallum T, et al. Acute methionine loading does not alter arterial stiffness in humans. J Cardiovasc Pharmacol 2001;37:1-5.
38. Nestel PJ, Chronopoulos A, Cehun M. Arterial stiffness is rapidly induced by raising the plasma homocysteine concentration with methionine. Atherosclerosis 2003;171:83-6.
39. Hämelahti P, Järvinen O, Sisto T, et al. Methylenetetrahydrofolate reductase gene C677T mutation is related to the defects in the internal elastic lamina of the artery wall. Eur J Clin Invest 2002;32:869-73.
40. Hultberg B, Andersson A, Isaksson A. Higher export rate of homocysteine in a human endothelial cell line than in other human cell lines. Biochim Biophys Acta 1998;1448:61-9.